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The granting of clinical staff privileges is one of the primarymechanisms used by institutions to uphold the quality of
care. The Joint Commission on Accreditation of Healthcare
Organizations requires that the granting of initial or continuing
medical staff privileges be based on assessment of applicants
against professional criteria specified in medical staff bylaws.
Physicians and other healthcare providers are thus charged with
identifying the criteria that constitute professional competence
and with evaluating their peers accordingly. The process of
evaluating clinical knowledge and competence is often con-
strained by the evaluator’s own knowledge and ability to elicit
the appropriate information, a problem that is compounded by
the growing number of highly specialized procedures for which
privileges are requested.
The American College of Cardiology (ACC)/American
Heart Association (AHA)/American College of Physicians–
American Society of Internal Medicine (ACP-ASIM) Task
Force on Clinical Competence was formed in 1998 to develop
recommendations to attain and maintain the cognitive and
technical skills necessary for the competent performance of a
specific cardiovascular service, procedure, or technology.
These documents are evidence based, and where evidence is
not available, expert opinion is called upon to formulate
recommendations. Indications and contraindications for spe-
cific services or procedures are not included in the scope of
these documents. Recommendations are intended to assist
those who must judge the competence of cardiovascular
healthcare providers entering practice for the first time and/or
those who are in practice and undergo periodic review of their
practice expertise. Because the assessment of competence is
complex and multidimensional, isolated recommendations
contained herein may not necessarily be sufficient or appro-
priate for judging overall competence. Board specialty certi-
fication is not a required part of these recommendations but is
another measure of expertise.
Introduction
This statement is a revision and extension of the previous
ACP/ACC/AHA Task Force Statement on Clinical Compe-
tence in Exercise Testing (1). This statement is designed to
assist in the assessment of competence in stress testing. The
minimum education, training, experience, and cognitive and
procedural skills necessary for competent performance and
interpretation of exercise testing are specified. When possi-
ble, these are based on published data linking these factors
with competence in certain procedures or, in the absence of
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such data, on consensus of expert opinion. They are applica-
ble to most practice settings and can accommodate a variety
of ways to substantiate competence in the performance of
specific cardiovascular procedures.
Committee members were selected from cardiovascular
specialists involved in academic medicine and the private
practice community. The Writing Committee was broadened
to include an exercise physiologist, as well as members of the
American Academy of Family Physicians, the American
Society of Echocardiography (ASE), and the American So-
ciety of Nuclear Cardiology (ASNC). Representation by an
outside organization does not necessarily imply endorsement.
In addition to content peer reviewers, “official” reviewers
were provided by the ACC, AHA, ACP-ASIM, ASE, ASNC,
and the American Board of Internal Medicine (ABIM). This
document was approved for publication by the governing
bodies of the ACC and the AHA. In addition, the governing
boards of the ASE and the ASNC formally endorsed this
document.
The ACC/AHA/ACP-ASIM Task Force on Clinical Com-
petence makes every effort to avoid any actual or potential
conflicts of interest that may arise as a result of an outside
relationship or personal interest of a member of the writing
panel. Specifically, all members of the writing panel are
asked to provide disclosure statements of all such relation-
ships that might be perceived as real or potential conflicts of
interest. These statements are reviewed by the ACC/AHA/
ACP-ASIM Task Force on Clinical Competence, reported
orally to all members of the Writing Committee at the first
meeting, and updated at each meeting or as changes occur.
Document Format
This document addresses competence for performing a broad
variety of stress tests. This work discusses the cognitive and
training skills necessary for competent performance of exer-
cise and pharmacological stress and includes consideration of
stress echocardiography and radionuclide cardiac imaging. In
recognition that the performance of many complex stress tests
(eg, stress radionuclide cardiac imaging) involves a “division
of labor,” this document will describe the specific skills
necessary to supervise* the study, interpret the images, and
integrate the component results of the study. Furthermore,
this work describes the cognitive and training requirements
necessary for competence in administering stress testing to
children and adolescents. Accordingly, this document is
presented in 4 sections: 1) exercise electrocardiographic
(ECG) testing, 2) stress echocardiography, 3) stress radionu-
clide cardiac imaging, and 4) pediatric exercise testing.
Several different modes of physiological stress are now
commonly used in stress testing. Section 1 will emphasize the
skills needed to perform dynamic exercise tests (eg, tread-
mill). Section 2 will elaborate on the skills and training
necessary to perform adrenergic-stimulating agent (eg, dobu-
tamine) stress testing. Section 3 will develop the cognitive
skills and training necessary to perform vasodilating-agent
(eg, adenosine) stress testing. Finally, section 4 addresses the
differences of many of the testing standards between the adult
and pediatric populations and provides information on the
skills necessary to perform metabolic measurements during
stress testing.
Maintaining Competence: Quality Assurance
This Writing Committee strongly recommends that a com-
prehensive program of quality assurance be established in
each center to assist in the maintenance of competence in the
performance of all stress tests. When possible, the results of
stress tests should be compared with the findings at cardiac
catheterization, cardiac surgery, and necropsy to assess the
validity of the test findings. Periodic review of a random
sample of stress studies that have been interpreted by an
individual physician should be performed by a qualified
unbiased expert, either from the physician’s own institution
or, when necessary, from another laboratory. This review
would help to confirm that the specific stress examinations
were clinically indicated, were technically complete and of
adequate technical quality, and were interpreted correctly and
reported in an effective manner to healthcare providers and to
the patient’s medical record.
Section 1: Exercise ECG Testing
Overview of the Procedure
Exercise testing has been used in clinical practice for many
years, and its use has contributed significantly to the man-
agement of many patients. In its current form, clinical
exercise testing consists of the continuous monitoring of an
ECG (generally a 3-lead or a 12-lead system) with frequent
recordings of 12-lead tracings. Additional tracings are taken
according to clinical circumstances. Frequent blood pressure
determinations are made before, during, and after exercise of
progressively increasing intensity (usually with a treadmill or
cycle ergometer) to any of a number of test end points.
In many instances, exercise testing may be combined with
other procedures, such as myocardial perfusion imaging,
radionuclide ventriculography, echocardiography, magnetic
resonance imaging, or metabolic measurements. If a physi-
cian is responsible for both exercise testing and imaging,
clinical competence in both areas is required. In other cases,
one physician may be responsible for the exercise test and
another for imaging. In such cases, staff privileges are
granted accordingly. As discussed below, exercise testing is
frequently conducted with a division of labor, by which one
individual is competent to supervise the study and a second
individual is competent to interpret the study.
Because exercise testing entails a very small but definite
risk, and data confirm that up to 1 myocardial infarction or
death per 2500 tests (2) occurs, it should be performed only
under the following conditions: with appropriate indications
and careful consideration of contraindications, under the
supervision of a properly trained physician or individual (eg,
an exercise physiologist), and with appropriate technique and
safety measures. The interpreting physician or individual
should know that the positive and negative predictive values
*For the purposes of this article we have defined the 3 levels of
supervision for diagnostic tests as follows: 1) “personal supervision”
requires a physician’s presence in the room; 2) “direct supervision”
requires a physician to be in the immediate vicinity or on the premises or
the floor and available for emergencies; and 3) “general supervision”
requires the physician to be available by phone or by page.
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of the test can vary considerably according to the prevalence
of the condition in the population being tested (Bayes’
theorem) and that the sensitivity and specificity vary accord-
ing to the criteria used to determine a “positive,” “negative,”
or “indeterminate” result. The individual performing the test
must understand the many factors that can result in false-
positive, false-negative, or indeterminate results.
The clinical indications for exercise testing are broad and
varied. In general, the procedure is used to answer a specific
question and should not be performed if the information
gained may be obtained with other techniques that have been
or will be performed, including the history and physical
examinations. Exercise testing should be conducted when it is
anticipated that the results will affect patient management. It
is important that the individual performing an exercise test
know the indications for and diagnostic accuracy of other
tests used in the evaluation of patients with known or
suspected cardiovascular diseases. Such tests include radio-
nuclide ventriculography, nuclear magnetic resonance imag-
ing, echocardiography, electron beam computed tomography,
other imaging methods, ambulatory electrocardiography, and
cardiac catheterization, and exercise testing combined with
myocardial perfusion imaging, first-pass or equilibrium ra-
dionuclide angiography, or echocardiography.
For the purpose of this statement, performance of exercise
testing includes that the individual know the indications for
and contraindications to the test, recognize normal end points
and abnormal responses or complications that may require
that the test be discontinued, manage complications of the
test, and interpret the test results. In most patients, exercise
testing can be safely supervised by properly trained nurses,
physician assistants, exercise physiologists, physical thera-
pists, or medical technicians working under the direct super-
vision of the physician, who should be in the immediate
vicinity or on the premises or the floor and available in case
of emergency situations (3,4). It is recommended that non-
physicians who supervise the actual exercise test have certain
cognitive skills (see Table 1, part I), and they may be certified
in exercise testing by organizations such as the American
College of Sports Medicine (5). In general, the physician
should be present to observe the patient continuously (ie,
personally supervise) when the test is performed on a patient
with a recent (within 7 to 10 days) history of documented
acute coronary syndrome, severe left ventricular dysfunction,
severe valvular stenosis (eg, aortic stenosis), or complex
arrhythmia. In all instances, the healthcare provider should
screen the patient for indications and contraindications im-
mediately before the test.† Competent performance of exer-
cise testing requires significant cognitive knowledge, includ-
ing clinical evaluation of the patient, knowledge of the
pathophysiology of the disease or condition for which the test
is performed, and knowledge of electrocardiography, cardiac
arrhythmias, and electrophysiology, including normal and
abnormal responses to different types and levels of exercise.
Justification for Recommendations
The number of procedures that must be performed under
supervision and the duration of training vary depending on
the individual’s aptitude, other training, and the clinical
complexity of their patients undergoing stress testing. The
following recommendations for minimum criteria for compe-
tence are based on the ACC’s Guidelines for Training in
Adult Cardiovascular Medicine (6) and the expert opinion of
cardiovascular consultants.
Indications, Contraindications, and Complications
Indications and contraindications for stress testing fall outside
the scope of this document but are included in the ACC/AHA
Practice Guidelines in Exercise Testing list of specific indi-
cations for exercise testing in cardiology patients (7). This
guideline divides recommendations into classifications as
follows. Class I represents those conditions for which there is
†There may be other circumstances determined by the clinical situa-
tion of the patient that would require the physician to be personally
present. All of these situations are so broad that they are beyond the
scope of this document.
TABLE 1. Cognitive Skills Needed to Competently Perform
Exercise Tests
I. Cognitive skills needed to competently supervise exercise tests
c Knowledge of appropriate indications for exercise testing
c Knowledge of alternative physiological cardiovascular tests
c Knowledge of appropriate contraindications, risks, and risk assessment
of testing (not limited to Bayes’ theorem and sensitivity/specificity,
including concepts of absolute and relative risk)
c Knowledge to promptly recognize and treat complications of exercise
testing
c Competence in cardiopulmonary resuscitation and successful
completion of an AHA-sponsored course in advanced cardiovascular
life support and renewal on a regular basis
c Knowledge of various exercise protocols and indications for each
c Knowledge of basic cardiovascular and exercise physiology, including
hemodynamic response to exercise
c Knowledge of cardiac arrhythmias and the ability to recognize and
treat serious arrhythmias
c Knowledge of cardiovascular drugs and how they can affect exercise
performance, hemodynamics, and the ECG
c Knowledge of the effects of age and disease on hemodynamic and
ECG responses to exercise
c Knowledge of principles and details of exercise testing, including
proper lead placement and skin preparation
c Knowledge of end points of exercise testing and indications to
terminate exercise testing
II. Additional cognitive skills needed to competently interpret exercise tests
c Knowledge of specificity, sensitivity, and diagnostic accuracy of
exercise testing in different patient populations
c Knowledge of how to apply Bayes’ theorem to interpret test results
c Knowledge of electrocardiography and changes in the ECG that may
result from exercise, hyperventilation, ischemia, hypertrophy,
conduction disorders, electrolyte disturbances, and drugs
c Knowledge of conditions and circumstances that can cause
false-positive, indeterminate, or false-negative test results
c Knowledge of prognostic value of exercise testing
c Knowledge of alternative or supplementary diagnostic procedures to
exercise testing and when they should be used
c Knowledge of the concept of metabolic equivalent (MET) and
estimation of exercise intensity in different modes of exercise
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evidence and/or general agreement that a given procedure or
treatment is useful and effective. Class II represents condi-
tions for which there is conflicting evidence and/or a diver-
gent opinion about the usefulness/efficacy of a procedure or
treatment. In class IIa, the weight of evidence/opinion is in
favor of the usefulness/efficacy. In class IIb, the usefulness/
efficacy is less well established by evidence/opinion. Class III
conditions are those in which there is evidence and/or general
agreement that the procedure/treatment is not useful/effective
and in some cases may be harmful.
It is important to note that ’90% of middle-aged men with
a history consistent with typical angina have significant
coronary artery disease when studied by coronary arteriogra-
phy (7). In such patients, an exercise test adds only slightly to
the diagnostic accuracy of the clinical impression, although it
may provide important information regarding prognosis and
work capacity. In contrast, the prevalence of significant
coronary artery disease as measured by angiography in
women with a history of typical angina pectoris may be as
low as 60% to 70%. The general pretest probability of
coronary artery disease by age, sex, and symptoms is shown
in the Practice Guidelines for Exercise Testing (7,8).
Minimum Training Necessary for Competence
It is important to distinguish between those skills and knowl-
edge necessary for supervision of the test and those skills and
knowledge necessary to interpret the entire exercise test.
Table 1, part I lists the cognitive skills necessary to supervise
exercise tests competently. Individuals who interpret exercise
tests should also have the cognitive skills listed in Table 1,
part II.
Many physicians acquire the skills necessary for supervi-
sion and/or interpretation of exercise testing during a fellow-
ship in cardiovascular disease. Some internal medicine and
family practice residency programs provide training in exer-
cise testing, often as an elective. A minimum of 4 weeks or
the equivalent should be devoted to this training to achieve
competence in both supervision and interpretation.
Because of the variable backgrounds of physicians and the
diversity of their training experiences, multiple pathways to
acquire competence are possible. The clinical and institu-
tional setting in which the training occurs, the case mix,
backup, and collaboration available to trainees performing the
procedures, and the number of procedures performed under
supervision must all be considered when privileges are
granted.
The number of procedures necessary to ensure competence
has not been established by objective criteria. The majority
opinion of this committee and its consultants is that the
trainee should participate in at least 50 procedures during
training. It is recognized that not all training or practice
environments are the same, and a local credentials committee
may deem a greater or smaller number of procedures
appropriate.
Physicians who did not receive formal training for the
supervision or interpretation of exercise testing during a
residency or fellowship but who are currently performing
exercise testing should have gained appropriate experience
under the supervision of a physician or healthcare provider
qualified in exercise testing. Such postgraduate training may
have included didactic courses and workshops, personal
tutorials, and importantly, exercise testing performed under
the supervision of a qualified physician. For physicians who
finished training without the opportunity for such formal
training but who have performed exercise testing on a regular
and substantial basis for more than 3 years (minimum 150
procedures), experience may be considered individually in
lieu of formal training. In any setting, training must result in
the acquisition of the cognitive skills outlined in Table 1.
While acquiring the knowledge and skills of exercise
testing as part of a formal training program or subsequently,
the physician should be supervised by an effective teacher
who is an expert in the clinical use of exercise testing and
who performs this on a regular basis. The trainee’s experience
should be documented in writing and confirmed by the
supervisor. Trainees who have acquired the additional cog-
nitive skills necessary to interpret exercise ECG tests (see
Table 1, part II) should obtain specific confirmation from
their supervisor.
The completion of a short course or workshop that offers a
limited cognitive background in cardiology or inadequate
hands-on experience with the procedure will not by itself
result in competence.
Maintenance of Competence
Continuing competence in exercise testing requires regular,
continued performance of exercise testing. Performance of
only a rare test can lead to missed or inappropriate diagnoses
and decreased overall accuracy and may lead to a higher rate
of complications. The appropriate number of exercise tests
that individuals should perform to maintain competence in
the supervision and interpretation of these tests has not been
established by evidence-based studies. On the basis of a prior
survey of practicing general internists (9) and unpublished
data from a 1998 survey of cardiovascular experts by this
committee, we recommend that physicians perform at least 25
exercise tests per year to maintain their competence. A
program of quality assurance should be in place at each center
to ensure systematic review and critique of a significant
sample of exercise ECG cases. In addition, successful com-
pletion of a course in advanced cardiovascular life support
and renewal on a regular basis is recommended.
Section 2: Stress Echocardiography
Overview of the Test
Exercise Echocardiography
Imaging modalities such as echocardiography can be com-
bined with exercise ECG in an attempt to increase the
sensitivity and specificity of stress testing, as well as to
determine the extent of myocardium at risk for ischemia.
Echocardiographic images at rest are compared with those
obtained while the patient performs supine or upright station-
ary cycling or immediately after treadmill exercise. Images
must be obtained within 1 to 2 minutes after exercise, because
abnormal wall motion normalizes rapidly after exercise is
discontinued. Rest and stress images are compared side by
side in a cine loop display that is gated during systole from
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the QRS complex. Myocardial contractility normally in-
creases with exercise, whereas ischemia causes hypokinesis,
akinesis, or dyskinesis of the affected segments. A test is
considered positive if wall motion abnormalities develop with
exercise in previously normal territories or worsen in an
already abnormal segment (10). The diagnostic accuracy and
prognostic value of exercise echocardiography are fully
described in other sources (11–13). Complications during
exercise echocardiography are no different from those during
exercise ECG testing, because the echocardiographic proce-
dure itself has no known risks.
Pharmacological Stress Echocardiography
Pharmacological agents can be used to increase cardiac work
in lieu of exercise or cause coronary arterial vasodilation to
increase myocardial blood flow. Adrenergic-stimulating
agents, such as dobutamine, increase myocardial contractility,
heart rate, and blood pressure. Dobutamine is infused intra-
venously starting at 5 mg z kg21 z min21 and, if tolerated,
increased every 3 minutes thereafter by 5 to 10 mg z kg21 z
min21 until a maximal dose of 40 to 50 mg z kg21 z min21 is
reached or an end point is achieved. Atropine may be given if
an adequate heart rate is not achieved or other end points have
not been reached at peak dobutamine dose. End points
include new or worsening wall-motion abnormalities, ade-
quate heart rate response, worsening arrhythmia, moderate
angina, intolerable side effects, and significant increase or
decrease in blood pressure. ECG, heart rate, blood pressure,
and echocardiographic images are obtained throughout the
infusion. Echocardiographic images are then gated during
systole and displayed in a quad screen format that allows
side-by-side comparison of baseline, low and intermediate
doses of dobutamine, and peak dobutamine (recovery images
may also be displayed). A new or worsening wall-motion
abnormality constitutes a positive test for ischemia (14).
Indications for termination of stress echocardiography with
adrenergic agents are fully described in the practice guide-
lines for the clinical application of echocardiography (11).
Complications during dobutamine infusion include nausea,
headache, tremor, and anxiety; angina and atypical chest
pain; and atrial and ventricular arrhythmias (15). Myocardial
infarction and death, although rare complications, have been
reported. Intravenous b-adrenergic blockers can be adminis-
tered for prolonged ischemic responses and/or tachyarrhythmias
that persist after discontinuation of dobutamine.
Vasodilators such as dipyridamole and adenosine can also
be used as stress agents to assess coronary perfusion during
echocardiography. These agents cause maximal coronary
arteriolar vasodilation, resulting in increases in flow to the
territory supplied by the normal epicardial coronary arteries.
If this increase in flow is sufficient, because the obstructed
artery does not allow an increase in flow, blood is directed
away from the territory supplied by the obstructed artery,
causing the “steal phenomenon.” Echocardiographic images
are obtained at baseline and after vasodilator infusion. As in
routine stress echocardiographic testing, a new or worsening
wall-motion abnormality constitutes a positive test for ische-
mia. Side effects are similar with adenosine and dipyridamole
but are reported more frequently with adenosine. Symptoms
include flushing, chest pain, headache, dyspnea, and atrioven-
tricular block and can be reversed with aminophylline (16).
Clinical Utility of Stress Echocardiography
The indications for stress echocardiography are outlined in
detail elsewhere (7,11). The addition of echocardiographic
imaging to exercise is particularly useful when the ECG
changes of ischemia are obscured by baseline abnormalities
(eg, left ventricular hypertrophy or resting repolarization
changes). Imaging also provides information regarding the
location of ischemic myocardium and the size of the territory
at risk. Exercise or pharmacological stress echocardiography
provides greater diagnostic accuracy than exercise ECG
alone, and thus these are useful procedures when the results
of the latter test are equivocal or indeterminate. Patients
unable to undergo exercise stress testing for reasons such as
deconditioning, peripheral vascular disease, orthopedic dis-
abilities, neurological disease, and concomitant illness can
often benefit from pharmacological stress testing. Indications
for these tests include establishing a diagnosis of coronary
artery disease, determining myocardial viability before revas-
cularization, assessing prognosis after myocardial infarction
or in chronic angina, and evaluating perioperative cardiac
risk.
With the addition of Doppler techniques, stress echocardi-
ography can also be used in selected patients with valvular
heart disease to assess left ventricular function during exer-
cise (17) and/or evaluate changes in transvalvular gradient
during exercise (18,19), particularly in patients whose symp-
toms are out of proportion to the severity of the lesion at rest.
Contraindications to exercise echocardiography are similar
to those for exercise ECG testing. Similarly, adrenergic-
stimulating agents should be avoided in patients with unstable
angina, hypokalemia, uncontrolled hypertension (resting sys-
tolic blood pressure .200 mm Hg or diastolic blood pressure
.110 mm Hg), uncontrolled congestive heart failure, and
uncontrolled dysrhythmias. Vasodilator agents should not be
used in patients with second- or third-degree atrioventricular
block (without permanent pacemakers) and patients with
chronic asthma or severe chronic obstructive lung disease (7).
Minimum Training Necessary for Competence
Stress echocardiography requires direct supervision during
the testing procedure, interpretation of the echocardiographic
images, and integration and interpretation of the composite
test data. In the case of exercise echocardiography, these roles
may be performed by a single physician or as many as 3
individuals with competence in each area. Pharmacological
stress testing, particularly with adrenergic agents, is often
performed by a single physician, because recognition of the
end points of such testing requires competence in both stress
testing and echocardiography.
The cognitive skills required to attain competence in direct
supervision of exercise echocardiographic tests are the same
as those outlined for exercise ECG testing (see Table 1). The
cognitive skills required for echocardiographic interpretation
and integration of composite test data are summarized in
Table 2. Such skills are acquired after completion of 6 months
of basic echocardiographic training, which includes perfor-
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mance and interpretation of at least 300 examinations within
1 year, 100 of which were performed for wall-motion analysis
(6,20). Specialized training in stress echocardiography re-
quires participation in at least 100 supervised stress exami-
nations and interpretations (beyond the basic 300 resting
echocardiography examinations) (6,20), of which 50 include
direct “hands-on” supervision of exercise stress and 50
include direct supervision during infusion of adrenergic-
stimulating pharmacological stress agents. These examina-
tions often involve the management of high-risk patients and
entail the performance of echocardiographic procedures that
cannot be readily repeated if the initial study is not of
diagnostic quality. The trainee must acquire a full understand-
ing of the principles, indications, applications, risks, and
limitations of stress echocardiography. The numbers of ex-
aminations listed are usually necessary but may not be
sufficient to adequately obtain the cognitive skills outlined in
Table 2. The training supervisor should be the judge of the
level of competence achieved by the trainee (20).
Echocardiographic training should be acquired under the
supervision of the laboratory director, designated faculty
members, and cardiac sonographers. This training should be
done in a laboratory that performs a minimum of 40 stress
echocardiograms per month (20). Training in stress echocar-
diography is best accomplished under the close supervision of
a fully qualified expert who regularly performs and interprets
these procedures. The training supervisor should have level 3
experience (6), with independent interpretation of .200
stress echocardiography studies, and should maintain the
skills that are outlined below (20). Optimal evaluation of
competence should be performed by direct observation of the
trainee to perform and interpret the stress echocardiogram, or
it may take the form of a practical or written examination, or
both (6). Observational evaluation should be done on a daily
basis by the director of the laboratory and/or associates and
must involve both practical and reading sessions.
Competence in interpretation of stress echocardiography
usually can be accomplished during formal structured expe-
rience in an established echocardiography laboratory during
cardiology fellowship training. Training for persons not
currently in formal training programs should be based on
several factors that include the timing of the most recent
formal echocardiographic training, the duration of practice
and current activity as an echocardiographer, and the dedica-
tion of the individual to acquiring the necessary cognitive
skills (6). The physician’s background experience should be
equivalent to that described above for fellowship trainees in
echocardiography. Additional expertise in interpretation of
stress echocardiograms may be obtained through a combina-
tion of on-site visits to an active laboratory (defined above)
and overreading of the trainee’s interpretations by an estab-
lished stress echocardiographer (defined above). Such train-
ing in stress echocardiography requires participation in the
same number of supervised stress examinations and interpre-
tations as outlined above for fellowship training.
Maintenance of Competence
The maintenance of competence in stress echocardiography
requires the regular performance of such examinations. There
are no scientific studies that address the optimal number of
stress echocardiographic examinations required to maintain
proficiency in this area. The ASE suggests that such can be
accomplished by the performance of 15 studies per month
(20). However, it is the consensus of this committee that an
individual should perform and/or interpret at least 100 stress
echocardiographic studies per year to maintain competence.
The committee believes that the physician who does stress
echocardiography less frequently will have difficulty main-
taining the technical and cognitive skills required of such
testing and will not be able to keep abreast of technical
developments in the field. Finally, a program of quality
assurance should be in place at each center to ensure
TABLE 2. Cognitive Skills Required for Performance of
Stress Echocardiography
I. Exercise echocardiography
A. Skills required for supervision of exercise echocardiographic testing
(see Table 1, part I)
c Knowledge of the indications of exercise echocardiography
c Knowledge of the limitations of exercise echocardiography
B. Skills required to interpret echocardiographic images acquired during
stress echocardiography
c Ability to independently perform and interpret an echocardiographic
and Doppler study that is diagnostic, complete, and quantitatively
accurate
c Ability to recognize common cardiovascular pathological entities,
including myocardial, pericardial, and valvular entities and diseases
of the great vessels
c Ability to name and locate left ventricular wall segments
c Ability to identify and quantify wall-motion abnormalities of the left
ventricle
c Ability to identify, locate, and quantify changes in left ventricular
wall motion
c Ability to quantify stenotic and regurgitant valvular abnormalities
c Ability to distinguish adequate from inadequate echocardiographic
data
c Ability to produce a cogent written report of the echocardiographic
findings
C. Skills required to integrate exercise testing and echocardiographic
data for composite final report
c Knowledge of specificity, sensitivity, and diagnostic accuracy of
exercise echocardiographic testing in different patient populations
c Knowledge of how to apply Bayes’ theorem to interpret test results
c Knowledge of electrocardiography and changes in the ECG that may
result from exercise, hyperventilation, ischemia, hypertrophy,
conduction disorders, electrolyte disturbances, and drugs
c Knowledge of coronary anatomy and relation to echocardiographic
findings
c Ability to apply Doppler data to the physiological changes that occur
during exercise
c Knowledge of conditions and circumstances that can cause
false-positive, indeterminate, or false-negative test results
c Knowledge of prognostic value of exercise echocardiographic testing
c Knowledge of alternative diagnostic procedures to exercise testing
c Knowledge of the concept of MET and estimation of exercise
intensity in different modes of exercise
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systematic review and critique of a significant sample of
stress echocardiographic cases.
Pharmacological Stress Echocardiography
Pharmacological stress testing, particularly with
adrenergic-stimulating agents, is often performed by a
single physician, because recognition of the end points of
such testing requires cognitive skills as listed in Table 2
for supervision of stress testing (I A) and interpretation
of echocardiographic images (I B), plus those listed in
Table 3.
Section 3: Stress Radionuclide
Cardiac Imaging
Overview
Radionuclide cardiac imaging has become established as an
important adjunct to exercise or pharmacological stress for
the evaluation of patients with known or suspected coronary
artery disease (21,22). It adds valuable diagnostic and prog-
nostic information for making clinical management decisions
regarding the need for cardiac catheterization, coronary
revascularization, or medical treatment. A major advantage of
radionuclide cardiac imaging is the ability to obtain this
information using nonexercise stress (23–27). The most
common nuclear cardiac imaging technique used with stress
testing is myocardial perfusion imaging, which involves
injection of a radionuclide tracer such as 201Tl or a 99mTc-
based organic agent such as sestamibi or tetrofosmin at the
time of peak coronary hyperemia induced by exercise, phar-
macologically induced vasodilation (with intravenous dipyr-
idamole or adenosine), or adrenergic stimulation (such as
with dobutamine). The common feature of the different
radionuclide perfusion agents is that they are taken up by
myocardium in proportion to coronary blood flow and can be
imaged with a nuclear imaging camera. Thus, areas of
reduced uptake seen on cardiac imaging correspond to hy-
poperfused or ischemic myocardium. Stress images are then
compared with resting or delayed images to distinguish
hypoperfused viable versus nonviable or infarcted
myocardium.
In addition to myocardial perfusion, radionuclide car-
diac imaging techniques can also be used to evaluate the
effect of stress on regional and global ventricular function
(28,29). Ventricular performance during stress has been
demonstrated to have important diagnostic and prognostic
implications that can affect patient management decisions.
In patients with nonischemic heart diseases, ventricular
function rather than perfusion is the first-order determinant
of prognosis and can be accurately assessed by radionu-
clide techniques. For these purposes, blood-pool radionu-
clide angiography provides the greatest accuracy and
reproducibility. This technique is based on the proportion-
ality between ventricular blood volume and radionuclide
tracer activity in the ventricular blood pool. It has the
advantage of being relatively insensitive to the geometric
irregularities of the ventricles that commonly are manifest
in patients with heart disease and that affect calculations of
volume derived from area-length methods used with other
imaging modalities such as echocardiography.
Radionuclide cardiac imaging can be performed by
planar techniques, but for myocardial perfusion imaging, it
is now most commonly acquired with a camera and
software equipped to perform tomography (single photon
emission computed tomography, or SPECT) (30,31). This
allows for better localization of perfusion defects and
better correlation with angiographic coronary anatomy.
Interpretation is performed by physicians who have re-
ceived specific training in nuclear cardiology. Although
interpretation must be made directly by physicians, com-
puter software is now available to allow quantification of
images, which can serve as supplemental information for a
final interpretive conclusion (30,31).
The 4 basic components of the stress radionuclide cardiac
imaging study include the following: 1) performance of the
stress test; 2) handling of the radioisotope and acquisition,
processing, and display of images; 3) interpretation of the
stress ECG; and 4) interpretation of the cardiac images. These
TABLE 3. Additional Cognitive Skills Necessary to Perform,
Interpret, and Report Pharmacological Stress Echocardiography
c Knowledge of the different types of pharmacological stress agents
c Knowledge of advantages and disadvantages of the different
pharmacological stress agents
c Knowledge of the indications for pharmacological stress echocardiography
and use of the different types of pharmacological stress agents
c Knowledge of the contraindications of pharmacological stress
echocardiography with different types of pharmacological stress agents
c Knowledge of the limitations of pharmacological stress echocardiography
with different types of pharmacological stress agents
c Knowledge of the pharmacokinetics of the different pharmacological
stress agents
c Knowledge of the physiological responses to different pharmacological
stress agents
c Knowledge of the side effects of different pharmacological stress agents
and how to manage them
c Knowledge of the complications of different pharmacological stress
agents and how to manage them
c Competence in cardiopulmonary resuscitation and successful completion
of an AHA-sponsored course in advanced cardiovascular life support and
renewal on a regular basis
c Knowledge of cardiovascular drugs and how they affect responses to
pharmacological stress agents
c Knowledge of electrocardiography and changes that may occur in
response to pharmacological stress agents
c Knowledge of the end points of pharmacological stress echocardiography
and indications for termination of a stress echocardiographic examination
c Knowledge of the sensitivity, specificity, and diagnostic accuracy of
pharmacological stress echocardiographic testing in different patient
populations
c Knowledge of the prognostic value of pharmacological stress
echocardiography
c Knowledge of coronary anatomy and relation to echocardiographic
findings
c Ability to apply Doppler data to the physiological changes that occur
during pharmacological stress
c Knowledge of the relationship of imaging results to the presence or
absence of myocardial viability
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may be supervised by 1 or more physicians, depending on
their training and experience. Supervision of the stress
component demands knowledge and experience of the spe-
cific stressor involved: exercise, vasodilator, or adrenergic-
stimulating agent. The healthcare professionals supervising
the test must have knowledge of the indications and contra-
indications for each of the modes of stress and understand the
advantages and disadvantages of each. The stress test itself
should be under direct supervision of a physician. The actual
imaging can be performed under the general supervision of an
appropriately trained and experienced physician.
Radionuclide cardiac imaging should be performed by
individuals properly trained to handle the imaging agents,
with supervision by physicians trained in radioisotope han-
dling. Radionuclide cardiac imaging may be performed at a
hospital or in an office-based setting provided that such
trained personnel are involved with the procedure.
Interpretation of the cardiac images may be made by
physicians who receive their training in either a cardiology,
nuclear medicine, or radiology training program. Physicians
must understand the causes of image artifacts, be able to
recognize them at the time of interpretation, and understand
how to correct them (32). They must be able to create a
meaningful report that effectively communicates the results
of the study so that the referring physician can make
appropriate management decisions based on the findings.
The clinical indications for stress radionuclide cardiac
imaging fall primarily into 2 broad categories: diagnosis of
coronary artery disease and risk stratification. In certain
situations, stress radionuclide ventriculography is indicated
for diagnostic evaluation and risk stratification of patients
with nonischemic diseases, such as valvular heart disease and
drug toxicity states. Guidelines for the clinical use of stress
nuclear cardiac imaging are described in detail in the report of
the ACC/AHA collaboration with the ASNC (16). As with all
testing, it is important to understand exactly what question is
being asked of a test. This will determine the proper condi-
tions of testing (eg, on or off cardiac medications) and what
stress or agent to use (eg, exercise versus pharmacological
stress).
As with exercise testing in general, performance and
supervision of stress radionuclide cardiac imaging includes a
general knowledge of indications and contraindications of the
test, including exercise, vasodilator, and adrenergic stress. In
selected patients, exercise or vasodilator stress can be per-
formed safely by properly trained nonphysician healthcare
professionals under direct physician supervision. In all in-
stances, before testing, the patient should be screened for
contraindications or high risk that would require personal
supervision by a physician.
Minimum Training Necessary for Competence in
Performing and Interpreting Stress Radionuclide
Cardiac Imaging
Training required for performance of basic exercise testing is
described above. Both the performance of pharmacological
stress and the integration of stress (exercise or pharmacolog-
ical) studies with radionuclide cardiac imaging require train-
ing beyond that necessary for standard exercise testing alone.
Specific training and experience for performing and super-
vising pharmacological stress in conjunction with radionu-
clide cardiac imaging should be equivalent to level 1 training
defined by the ACC Core Cardiology Training Symposium
(COCATS) Task Force 2 (Exercise Testing) (33) to include a
minimum of 2 months of training. The number of procedures
necessary to ensure competence has not been established by
objective criteria. However, the COCATS Task Force 2
described the minimum experience required for appropriate
level 1 training to be 100 procedures (including both exercise
testing and pharmacological stress); of these, at least 50 need
to be personally reviewed with a faculty member. It is the
consensus of the present committee that training for physi-
cians who desire to perform vasodilator stress studies should
include at least 50 cases of vasodilator stress. Interpretation of
stress radionuclide cardiac imaging requires training specifi-
cally designed to establish competence in nuclear cardiology.
Specific training and experience should be equivalent to level
2 training defined by the ACC COCATS Task Force 5
(Nuclear Cardiology) (34). This training is also the minimum
required for eligibility to take the certification examination
offered by the Certification Board of Nuclear Cardiology.
This includes a minimum of 4 to 6 months of training. The
number of procedures required to achieve competence has not
been established objectively. However, the COCATS Task
Force 5 indicated that appropriate level 2 training for nuclear
cardiology would include experience in correlative catheter-
ization/angiographic and radionuclide data in a minimum of
30 patients and a minimum of 300 cases consisting of diverse
types of procedures interpreted under supervision. In addi-
tion, hands-on direct experience with at least 35 patients
should include pretest evaluation, radiopharmaceutical prep-
aration, performance of the study, administration of the
dosage, calibration and setup of the gamma camera, setup of
the imaging computer, and processing of the data for display
after acquisition. Training for nuclear cardiology procedures
may be obtained in multiple programs, including residency/
fellowship training programs in cardiology, nuclear medicine,
and radiology. Because of the diverse knowledge necessary to
achieve clinical competence, it is expected that training in
nuclear cardiology may involve cooperation and interaction
between the different types of training programs. Ideally,
physicians who interpret nuclear cardiology studies will be
certified by the Certification Board of Nuclear Cardiology.
Physicians who did not receive formal training during a
residency or fellowship but who are currently performing
and/or interpreting stress radionuclide cardiac imaging stud-
ies should have obtained appropriate experience comparable
to level 2 COCATS training under the supervision of a
physician qualified in exercise testing, pharmacological
stress, and/or image interpretation. Physicians who have not
received formal supervised training but who have been
performing or interpreting stress radionuclide cardiac imag-
ing studies for more than 3 years on a regular and substantial
basis may have their experience considered on an individual
basis in lieu of such training. Regardless of type of training
obtained, stress radionuclide cardiac imaging studies should
be performed or interpreted only by individuals who have
acquired the cognitive skills outlined in Table 4.
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Maintenance of Competence
Continued competence in stress radionuclide cardiac imaging
requires that studies be performed and/or interpreted on a
regular, ongoing basis. Although the minimum annual num-
ber of stress radionuclide cardiac imaging studies required to
maintain competence has not been established scientifically,
it is the consensus of this committee that an individual should
perform and/or interpret at least 100 stress radionuclide
cardiac imaging studies per year to maintain competence. At
least some of these should include stress radionuclide ven-
triculography if such studies will continue to be interpreted.
This rate is consistent with that recommended for stress
echocardiography presented elsewhere in this document. A
program of quality assurance should be in place at each center
to ensure systematic review and critique of a significant
sample of stress radionuclide cardiac imaging cases. Further-
TABLE 4. Cognitive Skills Needed to Perform Stress Radionuclide Cardiac Imaging
A. Supervision of exercise stress (see Table 1, part I)
B. Supervision of vasodilator or adrenergic-stimulating agent stress
c Knowledge of appropriate indications
c Knowledge of appropriate contraindications
c Knowledge of advantages and disadvantages of different exercise and pharmacological stress for radionuclide cardiac imaging
c Knowledge of complications and ability to recognize and appropriately treat complications, including use of adenosine/dipyridamole antagonists such as
theophylline and aminophylline
c Competence in cardiopulmonary resuscitation and successful completion of an AHA-sponsored course in advanced cardiovascular life support and renewal
on a regular basis
c Knowledge of various vasodilator, adrenergic stress protocols
c Knowledge of the pharmacokinetics of vasodilator and adrenergic drugs
c Knowledge of basic cardiovascular physiology, including heart rate and blood pressure response to vasodilators and adrenergic-stimulating agents
c Knowledge of electrocardiography and changes that may occur in response to vasodilators or adrenergic-stimulating agents
c Knowledge of cardiac arrhythmias and their treatment, including high-grade ventricular arrhythmia and heart block
c Knowledge of cardiovascular drugs (and other agents, eg, caffeine) and their effects on vasodilator and adrenergic drugs
C. Interpretation and reporting of imaging results
c Knowledge of clinical use and safe handling of radiopharmaceuticals
c Knowledge of computer display, systems, standard formats for display of images (SPECT and planar), normalization of images
c Knowledge of technical sources of error (including motion, attenuation, adjacent/overlap uptake, and reconstruction and count statistic artifacts), ability to
recognize such errors and correct them
c Knowledge of image interpretation, including ventricular size, lung uptake (201Tl imaging), perfusion defect assessment (location, extent, severity,
reversibility), noncardiopulmonary findings, and integration of findings into final interpretation
c Knowledge of gated SPECT display, quality control, and interpretation of regional and global right ventricular and left ventricular function
c Knowledge of quantitative image analysis
c Knowledge of coronary anatomy and relation to cardiac images
c Knowledge of normal global and regional function, the physiological determinants of these characteristics, and the potential pathophysiological causes of
ventricular dysfunction
c Knowledge of reporting systems and ability to generate a coherent, meaningful report that maximizes clinical utility
D. Integration of clinical, stress, and radionuclide cardiac imaging data for final interpretation
c Knowledge of kinetics of uptake of radionuclide tracers that influence timing of injection and imaging
c Knowledge of advantages and disadvantages of different perfusion agents
c Knowledge of physiology of exercise or pharmacological stress that influences timing of stress and injection of radionuclide perfusion agent
c Knowledge of diagnostic information that stress radionuclide cardiac imaging adds to exercise testing
c Knowledge of sensitivity/specificity of stress radionuclide cardiac imaging for diagnosis of coronary artery disease
c Knowledge of improvement in diagnostic accuracy for coronary artery disease compared with exercise testing
c Knowledge of integration of perfusion and function results
c Knowledge of relationship of imaging results to presence or absence of myocardial viability
c Knowledge of prognostic value of stress radionuclide cardiac imaging in ischemic and nonischemic heart diseases
c Knowledge of impact of extent and severity of perfusion defects and reversibility on prognostic implications of imaging results in ischemic heart disease
c Knowledge of how to apply Bayes’ theorem to test results
c Knowledge of factors involved with generating preimaging probability of coronary artery disease (including age, sex, symptomatology, and stress ECG
results)
c Knowledge of impact of levels of stress, medications, and timing of perfusion agent injection on diagnostic sensitivity/specificity of imaging results
c Knowledge of improvement in diagnostic and prognostic value with radionuclide cardiac imaging compared with exercise testing
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more, successful completion of a course in advanced cardio-
vascular life support with renewal on a regular basis is also
necessary for persons who will be performing stress studies.
Section 4: Pediatric Exercise Testing
Overview of the Test
Exercise testing in the pediatric population and in patients
with congenital heart defects is fundamentally different from
routine adult stress testing. This difference is due to both the
population undergoing testing and the types of testing re-
quired in each population (7,35,36). Therefore, not surpris-
ingly, many of the standards for testing in the adult popula-
tion have little relevance for pediatric exercise testing.
Ischemic heart disease is rare in the pediatric population.
Most pediatric patients who undergo exercise testing do so to
evaluate nonischemic heart disease. The most common rea-
son is the evaluation of exercise performance in preoperative
or, more commonly, postoperative congenital heart defects.
Other common indications include cardiomyopathy and
exercise-induced arrhythmia or syncope. Increasingly, pedi-
atric cardiologists are also being called on in their role as
exercise physiologists to evaluate non–cardiac-exercise–re-
lated abnormalities such as exercise-induced bronchospasm
or other pulmonary and/or musculoskeletal abnormalities
(36). Recommendations regarding the indications for exercise
testing in the pediatric population have been published
previously (7).
Exercise performance and aerobic capacity can be inferred
in the pediatric population from endurance time on ergome-
ters. Although this type of testing does not directly measure
such values as maximal oxygen consumption or anaerobic
threshold, these values can be estimated from such studies. In
addition, assessment of ECG changes, the presence of ar-
rhythmias, and blood pressure response to exercise are readily
assessed.
Because physical working capacity and aerobic capacity
are often the most important measurements in a pediatric
exercise testing, direct measurement of metabolism by gas
exchange is frequently performed as part of pediatric exercise
testing (36,37). Commonly measured values include maximal
oxygen consumption, maximal carbon dioxide production,
maximal respiratory exchange ratio, and maximal cardiac
output, as well as measurements of oxygen consumption at
anaerobic threshold. Maximal work rate, heart rate, and blood
pressure responses are also measured. Pulmonary function
studies that evaluate performance both at rest and during
exercise are important. This is not only to assess for pulmo-
nary dysfunction but also because many congenital heart
defects have associated pulmonary abnormalities. Resting
spirometry is often performed. During exercise, minute ven-
tilation, tidal volume, respiratory rate, and the ratio of
physiological dead space to tidal volume are frequently
monitored.
Normal values for all the above measurements vary with
age and often with sex. Interpretation of these data requires
that the physician be familiar with the changes in children’s
responses to exercise as a consequence of age and pubertal
status (35). In addition, the physician needs to be familiar
with many of the expected variations in response to exercise
seen in various types of congenital heart defects (7,35,36).
In the actual performance of exercise testing in the pedi-
atric population, wide differences in age and size must also be
taken into account. Protocols and ergometers must be adapted
to children as young as 4 years of age up through adolescence
and young adulthood. Equipment needs (such as mask size,
dead space in equipment, and size of rebreathing bags) vary
with patient size. Protocols frequently used in adult patients
to assess myocardial ischemia are often inadequate to assess
the working capacity of young children with congenital heart
defects. Likewise, a protocol well suited to measure aerobic
fitness in a young child may be inadequate to measure aerobic
fitness in an adolescent (36).
Recommendations Regarding Training and
Competence for Pediatric Exercise Testing
Recommendations regarding clinical competence in pediatric
exercise testing present a number of difficulties. There are no
large pools of data available nationwide regarding the types
of exercise testing performed and the manpower usage in
pediatric practice groups. Data available from surveys of
adult exercise testing are not generally applicable to the
pediatric population. In addition, far fewer pediatric studies
are performed, and there are far fewer pediatric cardiologists
than adult cardiologists performing exercise tests. It is there-
fore difficult to make generalized recommendations for a
relatively small group of physicians.
To obtain some insight into the type of testing performed in
the pediatric population, an informal survey of 10 medium to
large academic pediatric cardiac programs was performed for
this committee. The centers had a median of 9 cardiologists
(range 5 to 27). A median of 380 tests per year (range 100 to
850) was performed at these institutions, with 88% of tests
(range 0% to 100%) using metabolic measurements. These
studies were usually read by a single physician in each center
(range 1 to 9). In the 7 centers with active fellowship
programs, the median number of studies observed by an
individual fellow in the course of training was 40 (range 18
to 60).
The large number of patients undergoing metabolic exer-
cise testing in this survey would suggest that a very large
percentage of pediatric exercise testing is at least in part
directed at assessing working capacity and aerobic capacity.
These tests are read by a very small number of individuals
(usually just 1) at any center. This tends to reflect the very
subspecialized body of knowledge in exercise physiology
required to accurately interpret metabolic data from pediatric
exercise testing. More physicians appear to participate in
exercise testing involving nonmetabolic measurements that
focus primarily on ECG and blood pressure responses.
Minimum Requirements Needed to Achieve and
Maintain Clinical Competence
Exercise Testing Without Metabolic Measurements
The skills necessary to perform this type of stress testing in a
pediatric population are similar to those requirements in adult
testing for ischemia and arrhythmias. In addition, the health-
care provider must be familiar with the unique ECG, heart
1450 ACC/AHA Clinical Competence Statement on Stress Testing
rate, and blood pressure responses in the pediatric populations
(35,36,38). These include both differences in healthy children
compared with healthy adults and the changes that occur in
the healthy pediatric population in response to aging (38).
The physician should be familiar with the expected response
to exercise in types of patients who routinely undergo
exercise testing with the types of congenital heart disease that
produce arrhythmias (7,35). The individual responsible for
the supervision of the exercise test should be familiar with the
indications and contraindications for exercise testing in the
pediatric population; they should also be familiar with the
indications for termination of a pediatric exercise study (36).
(See Table 5.)
Trainees in the task force survey listed above participate in
a median of 40 tests during the course of their fellowship.
Although these numbers would appear adequate to achieve
competence, the caveats listed in the section on adult testing
seem to hold true for pediatric testing. Individual training
circumstances must be taken into account when adequacy of
training is judged.
Requirements for maintenance of clinical competence
should be similar to those for physicians who test adults.
Because of the generally lower number of studies performed
in the pediatric population, the total number of studies a
physician performs in the pediatric population may be fewer.
It is nevertheless important to perform testing regularly to
maintain an adequate level of clinical competence.
Exercise Testing With Metabolic Measurements
Supervision
Because many of the data needed for interpretation of
metabolic measurements in an exercise test require posttest
computer processing, there are many instances in which it
may not be required that the physician who interprets these
data be present for the exercise test. The physician who
supervises the test, in many instances, does not need to be
able to interpret the metabolic data. He/she should be com-
petent to assess all data acquired in a routine nonmetabolic
exercise test as outlined in the above section. Most impor-
tantly, the monitoring individual should be familiar with all
the indications and contraindications for exercise testing, as
well as the indications for termination of a pediatric exercise
test (36). The need for the presence of a physician familiar
with interpretation of metabolic data during an exercise test
must be made on an individual basis. There will be tests for
which the physician’s presence is necessary to ensure proper
collection and subsequent interpretation of the metabolic
data.
Interpretation
Interpretation of pediatric metabolic exercise testing is a very
subspecialized field in exercise testing. As the committee
survey indicates, the number of pediatric cardiologists who
interpret these studies is quite small. Therefore, it is ex-
tremely difficult to set any specific guidelines regarding how
to obtain the fund of knowledge necessary for metabolic
exercise interpretation. Trainees wishing to learn these skills
generally study metabolic exercise testing as an adjunct to the
normal clinical skills that must be mastered as a part of a
pediatric cardiology fellowship. Pediatric cardiologists who
have completed training usually gain this knowledge by a
combination of direct mentoring and texts. Minimal recom-
mendations are summarized in Table 6.
It is not possible to give recommendations about specific
numbers or types of studies that an individual should perform
to achieve clinical competence. In most cases, this decision
would appear to be best made by the individual physician
who mentors the trainee. These decisions should obviously
take into account the clinical circumstances under which the
trainee is likely to function subsequent to completion of
training.
Requirements for maintaining clinical competence are also
difficult to establish. The physician should be familiar with
the data outlined in the overview section of this report for
TABLE 5. Cognitive Skills Needed to Supervise and Interpret
Nonmetabolic Pediatric Exercise Tests
Knowledge as specifically applies to the pediatric population, including:
c Appropriate indications for exercise testing
c Absolute and relative contraindications to testing
c Appropriateness of the need for physician presence during testing
c Competence in pediatric cardiopulmonary resuscitation and successful
completion of an AHA-sponsored course in pediatric advanced life
support and renewal on a regular basis
c Knowledge of the type of ergometers used and modifications
necessary for pediatric use
c Knowledge of basic cardiovascular and exercise physiology as it
applies to various pediatric populations, including
a. ECG, heart rate, and blood pressure response to exercise in the
healthy pediatric and adolescent population
b. Expected response to exercise in various types of patients with
congenital cardiac defects who have or have not undergone surgery
c. Knowledge of the cardiac arrhythmias expected with exercise in
various types of pediatric cardiac abnormalities and their
appropriate treatments
c Knowledge of the appropriate end points for pediatric exercise testing
TABLE 6. Cognitive Skills Needed to Interpret Pediatric
Exercise Testing With Metabolic Measurements
c Familiarity with the normal age- and sex-appropriate responses to
exercise in healthy children for the following:
a. Working capacity, including those effects related to types of
ergometers used in testing
b. Oxygen consumption, including concepts of maximal V˙O2 as relevant
to the pediatric population, relationship of V˙O2 to work rate, factors
(cardiovascular, pulmonary, and musculoskeletal) that potentially
limit maximal V˙O2
c. Evaluation of and techniques to assess anaerobic threshold
d. Cardiac output, stroke volume, heart rate responses
e. Pulmonary function relevant to exercise measured at rest and
during and after exercise
c Familiarity with the expected metabolic responses to exercise for
various types of congenital and acquired heart defects, including the
unique physiology resulting from unrepaired or palliated heart defects
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pediatric metabolic exercise testing (7,35–39). Given the
specialized nature of this fund of knowledge, there are no data
that would suggest how many studies per year are necessary
to maintain clinical competence. The information from the
committee survey is reassuring, however, suggesting that
most physicians who interpret pediatric metabolic exercise
tests evaluate a substantial number of studies on a yearly
basis.
Stress Echocardiography, Nuclear Imaging, and
Pharmacological Stress Testing in
Pediatric Patients
These studies are performed in very small numbers in the
pediatric population. They are performed to evaluate condi-
tions associated with potential coronary insufficiency, such as
Kawasaki disease, cardiac transplant graft vasculopathy, the
arterial switch operation, and supervalvular aortic stenosis.
These conditions may be due to either an acquired or a
congenital cardiac abnormality. In most cases, these studies
are performed with the same protocols and measurement
techniques as in adult studies.
Very few pediatric centers perform significant numbers of
these studies. At these centers, the numbers performed may
be insufficient to provide adequate training for these types of
studies during fellowship. It may also be difficult to maintain
clinical competence with such a small number of studies. It
would therefore appear advisable that a pediatric cardiologist
who wishes to perform these types of procedures have a
relationship with an adult cardiology center, which could
serve as a resource for additional expertise in both the
performance and interpretation of certain studies.
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